GRO [AGRIA] 6-K: (Original Filing)

[Agria Announces Date of Annual General Meeting BEIJING, March 14, 2013 -- Agria Corporation (NYSE: GRO) (the Company or Agria) today announced that that its annual general meeting will be held at 9:30 a.m. Hong Kong Time on April 24, 2013 at 26th Floor, Gloucester Tower, The Landmark, 15 Queens Road Central, Hong Kong.], [AGRIA CORPORATION (THE COMPANY) NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Notice is hereby given that the annual general meeting of shareholders in the Company (the AGM) will be held at 26th Floor, Gloucester Tower, The Landmark, 15 Queens Road Central, Hong Kong at 9:30 a.m. (Hong Kong Time) on April 24, 2013 for the], [FORM OF PROXY SHAREHOLDERS ONLY AGRIA CORPORATION FOR USE AT THE ANNUAL GENERAL MEETING (AGM) TO BE HELD ON APRIL 24, 2013 (OR AT ANY ADJOURNMENT THEREOF) THIS PROXY IS VALID ONLY WHEN SIGNED AND DATED For use at the AGM (or at any adjournment thereof) of the holders of ordinary shares of US$0.0000001 each]

By | 2016-01-10T15:11:03+00:00 March 14th, 2013|Categories: Chinese Stocks, GRO, SEC Original|Tags: , , , , , |0 Comments

GRO [AGRIA] 6-K: Agria Announces Date of Annual General Meeting BEIJING,

[Agria Announces Date of Annual General Meeting BEIJING, March 14, 2013 -- Agria Corporation (NYSE: GRO) (the Company or Agria) today announced that that its annual general meeting will be held at 9:30 a.m. Hong Kong Time on April 24, 2013 at 26th Floor, Gloucester Tower, The Landmark, 15 Queens Road Central, Hong Kong.], [AGRIA CORPORATION (THE COMPANY) NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Notice is hereby given that the annual general meeting of shareholders in the Company (the AGM) will be held at 26th Floor, Gloucester Tower, The Landmark, 15 Queens Road Central, Hong Kong at 9:30 a.m. (Hong Kong Time) on April 24, 2013 for the], [FORM OF PROXY SHAREHOLDERS ONLY AGRIA CORPORATION FOR USE AT THE ANNUAL GENERAL MEETING (AGM) TO BE HELD ON APRIL 24, 2013 (OR AT ANY ADJOURNMENT THEREOF) THIS PROXY IS VALID ONLY WHEN SIGNED AND DATED For use at the AGM (or at any adjournment thereof) of the holders of ordinary shares of US$0.0000001 each]

By | 2016-01-10T15:11:14+00:00 March 14th, 2013|Categories: Chinese Stocks, GRO, Webplus ver|Tags: , , , , , |0 Comments

XRS [TAL Education] CORRESP: (Original Filing)

[TAL EDUCATION GROUP 18/F, Hesheng Building 32 Zhongguancun Avenue, Haidian District Beijing 100080 People’s Republic of China March 14, 2013 VIA EDGAR Larry Spirgel, Assistant Director Carlos Pacho, Senior Assistant Chief Accountant Christine Adams, Senior Staff Accountant 100 F Street, N.E. Re: TAL Education Group (the “Company”) Form 20-F for the Fiscal Year Ended February 29, 2012 (the “2012 Form]

By | 2016-02-29T02:14:43+00:00 March 14th, 2013|Categories: Chinese Stocks, SEC Original, XRS|Tags: , , , , , |0 Comments

XRS [TAL Education] CORRESP: TAL EDUCATION GROUP 18/F, Hesheng Building 32 Zhongguancun

[TAL EDUCATION GROUP 18/F, Hesheng Building 32 Zhongguancun Avenue, Haidian District Beijing 100080 People’s Republic of China March 14, 2013 VIA EDGAR Larry Spirgel, Assistant Director Carlos Pacho, Senior Assistant Chief Accountant Christine Adams, Senior Staff Accountant 100 F Street, N.E. Re: TAL Education Group (the “Company”) Form 20-F for the Fiscal Year Ended February 29, 2012 (the “2012 Form]

By | 2016-02-29T02:16:06+00:00 March 14th, 2013|Categories: Chinese Stocks, Webplus ver, XRS|Tags: , , , , , |0 Comments

XRS [TAL Education] CORRESP: (Original Filing)

[TAL EDUCATION 18/F, Hesheng Building 32 Zhongguancun Avenue, Haidian District Beijing 100080 Peoples Republic of China March14, 2013 VIA EDGAR Larryirgel,sistant Directorrlos Pacho, Seniorsistant Chief Accountant Christineams, Senior Staff Accountant 100 F Street, N.E. Re: TAL Education (thempany) Form20-F for the Fiscal Year Ended February29, 2012 (the 2012 Form20-F)]

By | 2016-02-14T17:28:26+00:00 March 14th, 2013|Categories: Chinese Stocks, SEC Original, XRS|Tags: , , , , , |0 Comments

XRS [TAL Education] CORRESP: TAL EDUCATION 18/F, Hesheng Building 32 Zhongguancun Avenue,

[TAL EDUCATION 18/F, Hesheng Building 32 Zhongguancun Avenue, Haidian District Beijing 100080 Peoples Republic of China March14, 2013 VIA EDGAR Larryirgel,sistant Directorrlos Pacho, Seniorsistant Chief Accountant Christineams, Senior Staff Accountant 100 F Street, N.E. Re: TAL Education (thempany) Form20-F for the Fiscal Year Ended February29, 2012 (the 2012 Form20-F)]

By | 2016-02-14T17:30:21+00:00 March 14th, 2013|Categories: Chinese Stocks, Webplus ver, XRS|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-K: (Original Filing)

[FORM 10-K x For the fiscal year ended December 31, 2012 or ¨ For the transition period from _________ to _____________ China Pharma Holdings, Inc. Nevada 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Title of each class Name of each] [December 24, 2012 Dear Ms. Heung Mei Tsui On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc as a director. The compensation is $16,000 per year. I look forward to working with you. Your starting date will be the December 24, 2012, and] [Re: Service about being independent director, Chairman of the Nominating and Compensation Committee, and member of the Audit Committee of China Pharma Holdings, Inc. December 24, 2012 Dear Mr. Yingwen Zhang, On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an independent] [Re: Service about being independent director, member of the Audit Committee, and member of the Nominating and Compensation Committee of China Pharma Holdings, Inc. December 24, 2012 Dear Mr. Baowen Dong, On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an independent] [Re: Service about being independent director, chairman of the Audit Committee, and member of the Nominating and Compensation Committee of China Pharma Holdings, Inc. December 24, 2012 Dear Mr. Gene Michael Bennett, On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an] [Loans Extension Agreement With respect to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the Company), the principal and accumulated interest totaled USD $1,354,567 and $17,122 respectively as of December 31, 2012. Because the Company temporarily did not have enough balance in its oversea account to repay the loans, Ms. Tsui and the Company unanimously agreed] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 13, 2013 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this Annual Report on Form 10-K of China Pharma] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 14, 2013 President and Chief Executive Officer EX-32.1 10 cphi10kex321123112.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 14, 2013 (principal financial officer and principal accounting officer) EX-32.2 11 cphi10kex322123112.htm]

By | 2016-03-03T16:59:45+00:00 March 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-K: FORM 10-K x For the fiscal year ended

[FORM 10-K x For the fiscal year ended December 31, 2012 or ¨ For the transition period from _________ to _____________ China Pharma Holdings, Inc. Nevada 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Title of each class Name of each] [December 24, 2012 Dear Ms. Heung Mei Tsui On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc as a director. The compensation is $16,000 per year. I look forward to working with you. Your starting date will be the December 24, 2012, and] [Re: Service about being independent director, Chairman of the Nominating and Compensation Committee, and member of the Audit Committee of China Pharma Holdings, Inc. December 24, 2012 Dear Mr. Yingwen Zhang, On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an independent] [Re: Service about being independent director, member of the Audit Committee, and member of the Nominating and Compensation Committee of China Pharma Holdings, Inc. December 24, 2012 Dear Mr. Baowen Dong, On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an independent] [Re: Service about being independent director, chairman of the Audit Committee, and member of the Nominating and Compensation Committee of China Pharma Holdings, Inc. December 24, 2012 Dear Mr. Gene Michael Bennett, On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an] [Loans Extension Agreement With respect to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the Company), the principal and accumulated interest totaled USD $1,354,567 and $17,122 respectively as of December 31, 2012. Because the Company temporarily did not have enough balance in its oversea account to repay the loans, Ms. Tsui and the Company unanimously agreed] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 13, 2013 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this Annual Report on Form 10-K of China Pharma] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 14, 2013 President and Chief Executive Officer EX-32.1 10 cphi10kex321123112.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 14, 2013 (principal financial officer and principal accounting officer) EX-32.2 11 cphi10kex322123112.htm]

By | 2016-03-03T17:01:54+00:00 March 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar